New diagnostic test soon ready for the market

FDA beviljar fast track för prostataläkemedel

Rhovacs läkemedelskandidat för prostatacancer har beviljats fast track designation av FDA.

Drug development creates new challenges for regulators

Krönika: Can regulators keep up with innovation?

New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometimes referred to as precision medicine. Gene- and cell therapies have reached the market, exemplified by CAR-T cells, and the research pipeline is promising. In addition, the medical device field is constantly growing creating new solutions to address patient needs.